Of the more than 7.7 million people estimated to be living with sickle cell disease, more than 80% were in sub-Saharan Africa ...

Columnist Oluwatosin Adesoye discusses the ongoing dilemma with sickle cell pain management for both patients and healthcare ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

I wanted to start new habits at the end of last year instead of at the beginning of 2025. Several sources told me I didn’t need to wait until the start of a new year to make changes, so, in typical ...

It's not fully appreciated how much of an impact sickle cell disease can have on a person's mental health, writes columnist.

What is Oxbryta for sickle cell disease? Oxbryta (voxelotor), which is now withdrawn from the market due to safety concerns, was an oral small molecule conditionally approved in the U.S. for children ...

The Gates Foundation will invest up to $50 million to support Tessera's SCD gene editing treatment, the company said.

Columnist Oluwatosin Adesoye shares a list of things that everyone should know and understand about sickle cell disease.